Koite Health
Koite Health Oy is a Finnish medical technology company that develops light-activated photodynamic therapy devices (Lumoral, Lumoral Junior, Oncolum) for home-use antibacterial oral care, combining dual-light PDT with a consumable Lumorinse tablet sold by subscription through dental clinics, pharmacies, and e-commerce across 40+ countries.
- Company typePrivate
- Founded2018
- HeadquartersEspoo, Finland
- Headcount1–10
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Koite Health does
Koite Health Oy, founded in September 2018 in Espoo, Finland, is a venture-backed medical technology company that develops and commercializes light-activated antibacterial devices for oral healthcare. Its core platform, branded KOITE®, uses dual-light photodynamic therapy (PDT) combining 405nm violet light and 810nm near-infrared light to activate an indocyanine green (ICG) photosensitizer delivered via the Lumorinse mouthrinse tablet, generating singlet oxygen that selectively destroys pathogenic oral bacteria and biofilms without harming healthy tissue. The commercial product portfolio includes Lumoral (CE-marked Class IIa home-use PDT device for adults), Lumoral Junior (pediatric version for ages 4–12), and Oncolum (photobiomodulation device targeting oral mucositis in oncology patients), supported by the Lumoral 2.0 companion mobile application.
The company sells hardware (Lumoral and Lumoral Junior devices) to dental professionals and directly to consumers via its own e-commerce storefront and pharmacy chains, then generates recurring revenue through monthly subscriptions for Lumorinse consumable tablets. Distribution is multi-country and partner-led: Unident covers the Nordics, Megagen Iberia covers Spain and Latin America, white cross covers the DACH region, Elixiria Trading covers the UAE, HealthHub Pharma covers Poland, ProImplant covers Estonia and Latvia, Innodent covers Thailand, and in Sweden Apotek Hjärtat and Apoteket AB provide pharmacy retail. The company reports 40,000+ end users, 2M+ cumulative treatments delivered, an 88% recommendation rate among dental professionals, and 81% monthly subscriber retention on Lumorinse. It is EU MDR Class IIa certified (November 2025), ISO 13485 and ISO 9001 certified, holds CE marking (CE 0598), and is approved by the Australian TGA.
Koite Health operates in a stated €8.4 billion EU/US/China TAM for prevention and treatment of periodontal and peri-implant diseases. The company has raised over €9 million across three disclosed funding rounds and appointed Peter Rådqvist, a 30-year dental implant industry veteran (Nobel Biocare, Straumann, Zimmer Biomet, Bactiguard AB), as CEO in October 2025 to lead international expansion into France, Portugal, the USA, and adjacent indications including wound care.
Koite Health firmographics
Firmographics- Name
- Koite Health
- Legal name
- Koite Health Oy
- Website
- https://koitehealth.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Koite Health Oy is a Finnish medical technology company that develops light-activated photodynamic therapy devices (Lumoral, Lumoral Junior, Oncolum) for home-use antibacterial oral care, combining dual-light PDT with a consumable Lumorinse tablet sold by subscription through dental clinics, pharmacies, and e-commerce across 40+ countries.
- Ownership category
- akta.pro rank
Koite Health industry classification
Industry- Product category
- Oral Health Medical Devices
- NAICS
- Dental Equipment and Supplies Manufacturing (339114), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Dental Equipment & Supplies (3843), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Oral Care Products (Toothpaste, Mouthwash, Dental Floss, Whitening) (CRADAMAA)
Keywords
Where Koite Health is headquartered
LocationHeadquarters
- HQ city
- Espoo
- HQ country
- Finland
- HQ region
- Europe
Offices1 record
Markets served
Koite Health business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Marketing or Sales, Personnel, Operations
Revenue model
- Lumoral Device Sales: One-time hardware sales of Lumoral and Lumoral Junior PDT devices to dental clinics and directly to consumers via pharmacies and e-commerce. Initial product sales drive customer acquisition.
- Lumorinse Consumable Subscriptions: Recurring monthly subscriptions for Lumorinse ICG-activated mouthwash tablets, driven by the Lumoral 2.0 app's 81% monthly subscriber retention rate. App tracks treatments and automatically triggers consumable reorder reminders.
Go-to-market motion2 records
Distribution channels9 records
Marketing channels4 records
Koite Health product offering
Product offeringCore offering
Koite Health manufactures and sells the Lumoral and Lumoral Junior home-use antibacterial photodynamic therapy (PDT) devices, the Oncolum medical device for oral mucositis management, and the Lumorinse ICG-activated mouthrinse tablets used with the Lumoral device. Products are CE-marked Class IIa medical devices sold direct-to-consumer via e-commerce and pharmacy chains, and B2B via dental professional distributors and clinics across 40+ countries.
Product overview
Koite Health offers a portfolio of light-activated antibacterial medical devices for oral health care. The core product is Lumoral, a CE-marked Class IIa dual-light photodynamic therapy device that combines with Lumorinse mouthrinse tablets for home-based antibacterial treatment. The portfolio includes Lumoral Junior for pediatric patients, Oncolum for oral mucositis management in cancer patients, and a companion mobile application. The company is developing wound healing applications using the same technology platform. The business model combines device sales with recurring revenue from consumable Lumorinse tablets, with distribution through dental professionals, pharmacies, and local partners across European and international markets.
Differentiator
Problem solved
Functional benefit
Brands
- Lumoral: Light-activated antibacterial oral care product for treating and preventing gum disease and oral infections. CE-marked Class IIa medical device.
- Lumoral Junior
- Lumorinse
- Oncolum
Products and services
- Lumoral Light-activated antibacterial oral care device for adults using dual-light photodynamic therapy (aPDT) combining blue (405nm) and near-infrared (810nm) light with Lumorinse mouthrinse tablets to eliminate harmful plaque bacteria while preserving normal oral flora. CE-marked Class IIa medical device for home use as an adjunct to professional mechanical plaque removal for periodontitis, gingivitis, and peri-implantitis patients.
- Lumoral Junior Pediatric version of the Lumoral PDT oral care device adapted for children aged 4-12 years, using the same dual-light photodynamic therapy technology as the adult device. Indicated for children with elevated caries risk, orthodontic appliances, or early-stage gingivitis. CE-marked Class IIa medical device covered by the November 2025 EU MDR certification.
- Oncolum
Quantifiable outcome
- 99.9% kill rate against Streptococcus mutans in 2 minutes (in vitro study)
- +4 more outcomes
Companies that use Koite Health
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles4 records
Koite Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Koite Health partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core.
- ReaktorcoreFinnish software and technology consultancy that developed Koite Health's digital ecosystem, including the Lumoral 2.0 mobile application. Partnership covers mobile app development and digital platform integration.
- UnidentcoreNordic dental distributor with close to 300 employees across Sweden, Norway, Denmark, and Finland. Serves as the primary dental channel partner for Lumoral device distribution to dental clinics throughout the Nordics.
- Megagen IberiacoreDental distributor covering Spain and Latin American markets for Lumoral device distribution to dental professionals and clinics.
- Elixiria TradingcoreDental and medical products distributor operating in the UAE and broader Middle East region, distributing Koite Health's oral care devices.
- HealthHub PharmacorePharmaceutical and dental distributor for Poland, distributing Lumoral products through dental clinics and pharmacies.
- ProImplantcoreDental implant care distributor covering Estonia and Latvia, distributing Lumoral for peri-implantitis management in dental implant patients.
- Innodent TradingcoreDental distributor for Thailand market, distributing Koite Health's oral PDT products to dental professionals.
- Apotek HjärtatcoreSweden's largest pharmacy chain, offering Lumoral products through both online and physical pharmacy locations, enabling direct patient access to Koite Health's oral care devices.
- Apoteket ABcoreSwedish government-owned pharmacy chain. Lumoral products planned for physical store rollout starting February 2026, representing significant Swedish pharmacy market access.
- white cross GmbHcoreDental products distributor covering Germany, Austria, and Switzerland (DACH region), distributing Lumoral devices to dental professionals.
Scale indicators10 records
Recent moves8 records
Expansion highlights6 records
Koite Health competitors and assessment
Company assessmentEmerging players
- BURST Oral Care: US-based DTC oral care subscription brand (toothbrushes, whitening, floss). Comparable direct-to-consumer subscription motion targeting consumers seeking premium at-home oral care, though in adjacent categories rather than PDT.
- Bactiguard: Swedish-listed infection prevention company developing anti-adhesion coating technology for medical devices. Highly comparable thematically — Nordic infection-prevention medtech focused on reducing antibiotic reliance — and overlapping with Koite's AMR value proposition.
- Quip: US-based DTC oral care subscription brand offering electric toothbrushes, refill heads, toothpaste, and floss. Comparable subscription + app-driven engagement model and consumer oral care positioning, though without antibacterial or PDT technology.
Broad incumbents
- Colgate-Palmolive: Colgate is the dominant global oral care brand across toothpaste, mouthwash, and adjunct devices. Comparable end-customer (consumer oral hygiene), comparable recurring-revenue model via consumables, and a clear strategic threat if it enters light-based antibacterial therapy.
- Philips (Sonicare): Philips Sonicare is the global leader in premium home-use electric oral care devices. It is the most relevant broad incumbent competitor — overlapping end-customer (home-use oral hygiene), overlapping channel (dental professional recommendation + retail), and with sufficient R&D resources to potentially enter home-use antibacterial PDT.
- Procter & Gamble (Oral-B / iO): Oral-B is a leading global premium home-use oral care device brand (electric toothbrushes, including the iO connected platform). Comparable end-customer (mass-market + premium oral hygiene) and direct overlap in retail pharmacy and dental professional channels.
Direct peers
- Curaden (Curaprox): Swiss premium oral care brand (Curaprox) selling consumer toothbrushes, interdental brushes, and adjunct products through dental professionals and pharmacy. Direct comparable in premium home-use oral care sold via dentist recommendation + pharmacy channels.
- Dentaid: Spanish oral care company (Bexident, Interprox) selling mouthwashes, toothpastes, and interdental products through dental professionals and pharmacy. Comparable size and distribution model (clinics + pharmacy), with overlapping mouthwash product category to Lumorinse.
- Ondine Biomedical: Ondine Biomedical develops photodynamic therapy (PDT) products for nasal and oral infection prevention, including MRSA decolonization. The closest technology comparable — both firms are commercial-stage PDT antimicrobial companies targeting infection prevention, including in oral care settings.
- TePe: Swedish-headquartered oral hygiene company selling interdental brushes, toothbrushes, and specialty oral care products primarily through dental professionals. Direct comparable in premium oral care distributed via dental channel and pharmacy across Europe.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Koite Health social profiles
Digital presenceKoite Health compliance and trust
Trust signalCompliance5 records
Koite Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Koite Health leadership team
Management profileNumber of profiles
Profiles10 records
Koite Health funding detail
Funding detailFunding overview
Funding rounds3 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Koite Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Koite Health
What does Koite Health do?
Koite Health manufactures and sells the Lumoral and Lumoral Junior home-use antibacterial photodynamic therapy (PDT) devices, the Oncolum medical device for oral mucositis management, and the Lumorinse ICG-activated mouthrinse tablets used with the Lumoral device. Products are CE-marked Class IIa medical devices sold direct-to-consumer via e-commerce and pharmacy chains, and B2B via dental professional distributors and clinics across 40+ countries.
Is Koite Health a public or private company?
Koite Health is a private company. It is classified as venture growth investor backed and is currently operating.
When was Koite Health founded?
Koite Health was founded in 2018. It employs 1 to 10 people.
Where is Koite Health based?
Koite Health is headquartered in Espoo, Finland, in the Europe region.
How does Koite Health make money?
Two revenue lines are on record. Lumoral Device Sales are the primary driver. The others are lumorinse Consumable Subscriptions.
Who are Koite Health's main competitors?
Emerging players on record are BURST Oral Care, Bactiguard and Quip. Broad incumbents are Colgate-Palmolive, Philips (Sonicare) and Procter & Gamble (Oral-B / iO). Direct peers are Curaden (Curaprox), Dentaid, Ondine Biomedical and TePe.
Does Koite Health have an API?
No public API is recorded for Koite Health.
What industry is Koite Health in?
Koite Health's product category is Oral Health Medical Devices. Its primary akta.pro industry code is CRADAMAA, Oral Care Products (Toothpaste, Mouthwash, Dental Floss, Whitening). Its NAICS code is 339114 and its SIC code is 3843.